Use of EDG2 receptor in an animal model of heart failure

US7169612B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Evi Kostenis · Bonn, DE
• Paulus Wohlfart · Frankfurt am Main, DE
• Jochen Huber · Mittelbiberach, DE
• Kai Rosport · Planegg, DE
• Andreas Bueltmann · Munich, DE
• Christine Baumgartner · Munich, DE
• Götz Muench · Munich, DE
• Martin Ungerer · Martinsried, DE

Key dates

• Filing date: Nov 12, 2003
• Grant date: Jan 30, 2007
• Expiry date: Jun 5, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2710/10343
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

Mammals and myocardial mammal cells transformed with G protein coupled receptor EDG2 are presented for use in an animal model for heart failure.